Cargando…

Maternal Hypercholesterolemia May Involve in Preterm Birth

Maternal hypercholesterolemia during pregnancy is associated with an increased risk of preterm birth which is defined as <37 weeks of complete gestation. However, the underlying mechanism for the association between hypercholesterolemia and preterm birth is not fully understood. Macrophage, as on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jingfei, Hua, Lan, Luo, Fei, Chen, Jianlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309366/ https://www.ncbi.nlm.nih.gov/pubmed/35898280 http://dx.doi.org/10.3389/fcvm.2022.818202

Ejemplares similares

Applications of machine learning in familial hypercholesterolemia
por: Luo, Ren-Fei, et al.
Publicado: (2023)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Hypercholesterolemia and Lymphatic Defects: The Chicken or the Egg?
por: Miyazaki, Takuro, et al.
Publicado: (2021)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Screening and clinical characteristics analysis of familial hypercholesterolemia in a tertiary public hospital
por: Shen, Tianzhou, et al.
Publicado: (2023)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
por: Barrios, Vivencio, et al.
Publicado: (2022)

Maternal plasma and salivary anelloviruses in pregnancy and preterm birth
por: Kyathanahalli, Chandrashekara, et al.
Publicado: (2023)

Subclinical Changes in Left Heart Structure and Function at Preschool Age in Very Low Birth Weight Preterm Infants
por: Chang, Hung-Yang, et al.
Publicado: (2022)

Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia
por: Sarraju, Ashish, et al.
Publicado: (2019)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia
por: Sasaki, Kei, et al.
Publicado: (2022)

Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia
por: Wang, Yaodong, et al.
Publicado: (2022)

Prevalence of genetically defined familial hypercholesterolemia and the impact on acute myocardial infarction in Taiwanese population: A hospital-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)

Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome
por: Wang, Cheng, et al.
Publicado: (2022)

Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report
por: Blokhina, Anastasia V., et al.
Publicado: (2022)

Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation
por: Vuorio, Alpo, et al.
Publicado: (2021)

Pericoronary radiomics texture features associated with hypercholesterolemia on a photon-counting-CT
por: Kahmann, Jannik, et al.
Publicado: (2023)

Maternal plasma lipids are involved in the pathogenesis of preterm birth
por: Chen, Yile, et al.
Publicado: (2022)

Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia
por: Xu, Yitong, et al.
Publicado: (2022)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2021)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects
por: Yu, Yani, et al.
Publicado: (2022)

Paradoxical reduction of plasma lipids and atherosclerosis in mice with adenine-induced chronic kidney disease and hypercholesterolemia
por: Padalkar, Mugdha V., et al.
Publicado: (2023)

Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report
por: Feng, Siqin, et al.
Publicado: (2022)

COVID-19 Lockdown Increased the Risk of Preterm Birth
por: Lin, Ting-ting, et al.
Publicado: (2021)

Risk factors for heart, cerebrovascular, and kidney diseases: evaluation of potential side effects of medications to control hypertension, hyperglycemia, and hypercholesterolemia
por: Nawata, Kazumitsu
Publicado: (2023)

Persistent Coronary Vasomotor Tone During Myocardial Ischemia Occurs at the Capillary Level and May Involve Pericytes
por: Le, D. Elizabeth, et al.
Publicado: (2022)

Oral microbiome and preterm birth
por: Vidmar Šimic, Marijana, et al.
Publicado: (2023)

Developing a Hybrid Risk Assessment Tool for Familial Hypercholesterolemia: A Machine Learning Study of Chinese Arteriosclerotic Cardiovascular Disease Patients
por: Wang, Lei, et al.
Publicado: (2022)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative State
por: Louloudis, Georgios, et al.
Publicado: (2021)

Ostial Coronary Stenosis and Severe Aortic Stenosis in a Patient With Familial Hypercholesterolemia
por: Kaya, Hasan, et al.
Publicado: (2012)

Corrigendum: Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative State
por: Louloudis, Georgios, et al.
Publicado: (2022)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form − 5 Years Follow-Up
por: Vladimirova-Kitova, Lyudmila, et al.
Publicado: (2021)

Preterm Birth: An Overview
por: Khandre, Vivekanand, et al.
Publicado: (2022)

Painful and recurring injection site reaction to alirocumab and evolocumab in a young woman with familial hypercholesterolemia and effective therapeutic alternative based on inclisiran: a case report
por: Allevi, Massimiliano, et al.
Publicado: (2023)

Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics
por: Li, Yahong, et al.
Publicado: (2021)

Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomised waiting list controlled open-label study protocol
por: Nomura, Akihiro, et al.
Publicado: (2018)

Dose–response effect of postprocedural elevated cardiac troponin level on adverse clinical outcomes following adult noncardiac surgery: a systematic review protocol of prospective studies
por: An, Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d9p11faabiodq0gppt6qe658lf